Innovating diagnostics, shaping healthcare, changing lives

 

Oncology

Forecasting the future of cancer diagnostics

Our latest news

 

Roche receives FDA approval of label expansion for VENTANA PD-L1 (SP263) Assay to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for LIBTAYO
Lung Cancer
Roche receives FDA approval of label expansion for VENTANA PD-L1 (SP263) Assay

 

This testing provides essential information that helps guide clinical decision-making and may improve patient outcomes.

 

Read more

 

Kim’s Story: An Alzheimer’s caregiver
Alzheimer's
Kim’s Story: An Alzheimer’s caregiver

 

An Alzheimer’s diagnosis is scary, but living day by day allows her to continue ahead.

 

Read more

 

Claudia's Story: A heart attack survivor
Cardiometabolic
Claudia's Story: A heart attack survivor

 

She listened to what her body was telling her and never gave up.

 

Read more

 

Need help finding something? We’ve got you covered.

 

Products

Products

Learn more about our portfolio of lab instruments, systems, assays and more  

Begin exploring

Documents

Documents

More than 800,000 documents available on demand — always up-to-date with 24/7 access

Login to eLabDoc

Education

Education

Empowering learning — e-learning content, PACE/CEU courses, and more

Start training

Lab Leaders

Lab Leaders

Providing clinical and strategic insights, support, and solutions from industry innovators

Browse topics